Figure 4
From: Concurrent chemoradiotherapy in adjuvant treatment of breast cancer
Overall survival (OS): difference between the three anthracycline sub-groups: AC60, FEC75, and FAC50; Log-rank test: p = 0.982.
Figure 4 | Radiation Oncology